2 active not recruiting, 2 completed. 2 Phase 1, 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 2 |
| Early Phase 1 | 1 | Completed 1 |
Follow Proglumide: new trials by email Literature Review of Proglumide trials Research Report on Proglumide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proglumide and Chemotherapy for Metastatic Pancreatic Cancer Gemcitabine, Nab paclitaxel, Proglumide - Metastatic Pancreatic Cancer | Phase 2 | Active not recruiting | Georgetown University | 30 | 2024-01-31 | 2026-06-10 |
| Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis Proglumide, Placebo - Safety Issues, Pain | Phase 1 / Phase 2 | Active not recruiting | Georgetown University | 32 | 2022-11-17 | 2026-08-05 |
| Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment Proglumide - Cirrhosis, Liver | Early Phase 1 | Completed | Georgetown University | 11 | 2021-03-30 | 2022-03-15 |
| Safety and Tolerability of Oral Proglumide for NASH Proglumide - Nonalcoholic Steatohepatitis | Phase 1 | Completed | Georgetown University | 18 | 2019-12-13 | 2022-10-13 |
Diabetes Mellitus (1) · Liver Cirrhosis (1) · Non-alcoholic Fatty Liver Disease (1) · Pain (1) · Pancreatic Neoplasms (1) · Pancreatitis (1)
United States (4)
Jill P Smith, MD (3) · Benjamin Weinberg, MD (1)